SCHEMBL31729237

SCHEMBL31729237

O=C(O)N1CCC2OCOC2C1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TFPI2 P48307 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14964726 0.88 PDK1 (0.32) TFPI2
SCHEMBL666529 0.85 CHRNB2 (0.30)
SCHEMBL2692522 0.79 TFPI2 (0.39) TFPI2
SCHEMBL23152274 0.74 MGLL (0.32)
SCHEMBL26920368 0.73
SCHEMBL26920612 0.73
SCHEMBL15810106 0.72 HSD11B1 (0.37) TFPI2
SCHEMBL15810110 0.72 HSD11B1 (0.37) TFPI2
SCHEMBL16333249 0.72 HSD11B1 (0.37) TFPI2
SCHEMBL15810107 0.72 HSD11B1 (0.37) TFPI2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235797-A1 POTENT ASGPR-BINDING HETEROBIFUNCTIONAL COMPOUNDS COMPRISING ANTIBODIES FOR THE DEGRADATION OF TARGETED PROTEINS AVILAR THERAPEUTICS, INC. (US) 2025-11-13 WO disclosed